BIO-CSBA report explains why and how states seek to attract biotech
- Dec 2, 2025
- 1 min read
December 2, 2025 / Health, Latest News, State Policy / By Tom Popper
While U.S. biotech leadership is recognized as essential for national security, states also understand the industry’s local benefits and are implementing policies designed to attract and support their own biotech innovation ecosystems.
State-level pro-biotech policies are detailed in a new report, The U.S. Bioscience Industry: A Powerful Engine for State Economies, released Dec. 2 by the Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA).
BIO’s seventh biennial report on best practices in bioscience economic development initiatives details diverse strategies states use to strengthen their own bioscience ecosystem while supporting America’s global leadership in biotechnology.
“There’s encouraging progress, with a lot of legislation doing a good job of using public backing to leverage private support,” says Peter Pellerito, the author of the report. “Some 39 states have R&D tax credits. In our early reports several years ago, we had maybe 20 states with R&D tax credits. Clearly there is greater recognition of what the life sciences industry brings.”
Along with tax credits, governors and state legislatures are using many other creative initiatives to attract biotech firms and help those companies grow.
Why and how states support biotech
The benefits states receive from the bioeconomy include millions of jobs and a large economic impact for local communities.
“In 2023-2024, bioscience companies employed 2.3 million Americans across nearly 150,000 individual business establishments with a footprint in every U.S. state”, the report notes.
Comments